RT @The_JBMR: New results from ACTIVE and ACTIVExtend in #JBMR show 18 months of abaloparatide treatment improved #bone microarchitecture, and improvement was twice as large with abaloparatide/alendronate compared to alendronate alone. @ASBMR @WileyBiomedical https://t.co/tFmhojfBq9 https://t.co/jHW3eTnRf4


from Twitter https://twitter.com/GastonR48222321

February 17, 2023 at 08:18AM

Comentarios

Entradas más populares de este blog

Lunar iDXA